NMPA Product

Crizotinib Capsules

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Crizotinib Capsules

Generic Name

克唑替尼胶囊

Trade Name

赛可瑞

Strength

200mg

Dosage Form

胶囊剂

Regulatory Information

Approval Number

国药准字HJ20171008

Approval StatusApproved

Drug Type

化学药品

Approval Date

February 10, 2022

Company Information

ManufacturerPfizer Europe MA EEIG

Production Company

pfizer manufacturing deutschland gmbh, betriebsstatte freiburg

Active Ingredients

Crizotinib Capsules

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy